Abstract

The HOSPITAL score is a simple prediction model that accurately identifies patients at high risk of readmission and showed good performance in an international multicentre retrospective study. We aimed to demonstrate prospectively its accuracy to predict 30-day unplanned readmission and death. We prospectively screened all consecutive patients aged ≥50 years admitted to the department of general internal medicine of a large community hospital in Switzerland. We excluded patients who refused to give consent, who died during hospitalisation, or who were transferred to another acute care, rehabilitation or palliative care facility. The primary outcome was the first unplanned readmission or death within 30 days after discharge. Some of the predictors of the original score (discharge from an oncology service and length of stay) were adapted according to the setting for practical reasons, before the start of patient inclusion. We also assessed a simplified version of the score, without the variable "any procedure performed during hospitalisation". The performance of the score was evaluated according to its overall accuracy (Brier score), its discriminatory power (C-statistic), and its calibration (Hosmer-Lemeshow goodness-of-fit test). Among the 346 included patients, 40 (11.6%) had a 30-day unplanned readmission or death. The HOSPITAL score showed very good accuracy (Brier score 0.10), good discriminatory power (C-statistic 0.70, 95% confidence interval [CI] 0.62-0.79), and an excellent calibration (p = 0.77). Patients were classified into three risk categories for the primary outcome: low (59%), intermediate (20.8%) and high risk (20.2%). The estimated risks of unplanned readmission/death for each category were 8.2%, 11.3% and 21.6%, respectively. The simplified score showed the same performance, with a Brier score of 0.10, a C-statistic of 0.70 (95% CI 0.61-0.79), and a goodness-of-fit statistic of 0.40. The HOSPITAL score prospectively identified patients at high risk of 30-day unplanned readmission or death with good performance in medical patients in Switzerland. Its simplicity and good performance make it an easy-to-use tool to target patients who might most benefit from intensive transitional care interventions.

Highlights

  • Readmissions after an acute care hospitalisation are frequent and associated with significant burden for patients and healthcare systems

  • The HOSPITAL score has been shown to identify accurately medical patients at high risk for 30-day readmission and is currently one of the best validated readmission prediction models, with good performance shown in five countries and nearly 150 000 patients [1, 6, 7]

  • We looked at the performance of a simplified version of the HOSPITAL score that excluded the variable “procedure performed during the index hospitalisation”

Read more

Summary

Introduction

Readmissions after an acute care hospitalisation are frequent and associated with significant burden for patients and healthcare systems. Clinical providers are not able to identify accurately which patients are at high risk for readmission [5]. The HOSPITAL score has been shown to identify accurately medical patients at high risk for 30-day readmission and is currently one of the best validated readmission prediction models, with good performance shown in five countries and nearly 150 000 patients [1, 6, 7]. A prospective validation study is an essential step in the level of evidence [8,9,10]. It demonstrates the performance of the score and its practicability in real life.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call